If an appeal against a decision of the opposition division to maintain the patent in amended form is filed by both patentee and opponent, but later one of the appeals is withdrawn, the principle of reformatio in peius is still applicable, even if more limiting auxiliary claim sets have been filed by the patentee. Case…
The use of a generally available tool (here: reverse sandwich assays) can involve an inventive step if the advantages pursued and provided by the invention do not materialize without further effort and if the skilled person would not have found (sufficient) motivation in the state of the art to consider that this tool was suitable…
PTAB did not err in its claim construction or obviousness findings in two IPRs filed by Westinghouse that challenged two Siemens patents. Substantial evidence supported two Patent Trial and Appeal Board decisions following inter partes review of two related patents directed toward methods and systems for automatically activating a train warning device, including a horn,…
The Supreme Administrative Court held that the publication of an application for a European patent that included the description of an industrial design in the relevant journal before the protection for such design was requested meant that the relevant design had been made available to the public and thus was not eligible for registration. With…
The Court of appeal of Paris, in a decision on the merits, has ruled that the SPC covering the combination of ezetimibe and simvastatine is invalid. The decision was rendered on September 25, 2020, in a case opposing Merck and Teva (free translation available here).This is the first decision in Europe on the merits to…
The FCJ confirmed that the costs of the participation of a European Patent Attorney (Professional Representative before the EPO) in a patent case before the German civil courts are always recoverable from the losing party pursuant to sec. 143 (3) Patent Act. Case date: 14 April 2020 Case number: X ZB 2/18 (ECLI:DE:BGH:2020:140420BXZB2.18.0) Court: Federal…
This month the Mannheim Regional Court released a decision (here) in the dispute between Daimler AG, owner of the famous Mercedes-Benz brand, and the Finnish company Nokia (also see our previous post on this blog (Another CJEU ruling on standard-essential patents and FRAND looks inevitable). The controversy centred on Nokia’s European Patent EP2981103, which the German…
Declarations from generic drug makers alleged only possible future injury from implementation of the 2019 law that created a presumption that so-called “pay for delay” settlement agreements are anticompetitive. A trade association for the generic pharmaceutical industry failed to demonstrate standing to challenge a California law that created a presumption that “reverse payment” settlement agreements…
Another chapter in the pemetrexed saga: Barcelona Commercial Court No. 4 has ruled on infringement in the very first case worldwide concerning pemetrexed diarginine, a salt form of pemetrexed chosen by Sandoz in the wake of the outcome of the landmark Actavis case of the Supreme Court of the United Kingdom (Judgment dated 12 July…
In this decision, the German Federal Court of Justice deals with a number of practical issues concerning service inventions by German employees. In particular, it ruled on what must be contained in the employee’s inventor’s report and whether an assignment given by the employee in order to enable the employer to file for a US…
